These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
2/21/2019
7:30 AM ET
Earnings Release

Repligen Reports Fourth Quarter and Full Year 2018 Financial Results

2/21/2019

Record quarterly revenue of $51.9 million represents 25% year-over-year growth, and record annual revenue of $194.0 million represents 37% year-over-year growthOverall organic revenue growth was 25% f...

 Continue Reading
2/15/2019
7:30 AM ET
Press Release

Repligen to Report Fourth Quarter and Full Year 2018 Financial Results

2/15/2019

WALTHAM, Mass., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter and full year 2018 financial results on Thursday,...

 Continue Reading
1/3/2019
1:26 PM ET
Press Release

Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference

1/3/2019

WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at...

 Continue Reading
11/1/2018
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2018 Financial Results

11/1/2018

Record quarterly revenue of $49.5 million represents 35% year-over-year growth Revenue guidance raised to $191-$194 million for full year 2018 WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Repli...

 Continue Reading
10/22/2018
7:30 AM ET
Press Release

Repligen to Report Third Quarter 2018 Financial Results

10/22/2018

- Webcast and Conference Call to Be Held Thursday, November 1, 2018 at 8:30 a.m. EDT -

WALTHAM, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced...

 Continue Reading
Displaying 1 to 5 (of 224 releases)